Logotype for Mettler-Toledo International Inc

Mettler-Toledo International (MTD) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Mettler-Toledo International Inc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 sales declined 4% year-over-year to $946.8M, with strong laboratory sales in Europe and the Americas, but continued weakness in China and Industrial segments.

  • Productivity and margin initiatives helped offset foreign exchange headwinds and support earnings.

  • Service revenue grew 5–6% in Q2, building on double-digit growth in the prior year.

  • Management remains focused on digitalization, process harmonization, and gaining market share despite global market softness.

  • Net earnings for Q2 2024 were $221.8M, up 4% year-over-year, supported by a $23M one-time tax benefit.

Financial highlights

  • Q2 2024 sales were $946.8M, down 2% in local currency and 4% in USD; currency reduced sales growth by 2%.

  • Adjusted operating profit was $284.1M, down 8% year-over-year; adjusted operating margin at 30.0%, down 130 bps.

  • Adjusted EPS was $9.65, down 5% year-over-year; reported EPS was $10.37, including a $1.07 one-time tax benefit.

  • Adjusted free cash flow YTD was $433.4M, up 13% per share year-over-year.

  • Operating cash flow for the first half was $447.5M, up from $420.1M year-over-year.

Outlook and guidance

  • Q3 2024: Local currency sales expected to grow ~1%; adjusted EPS $9.90–$10.05; 1% FX headwind.

  • Full year 2024: Local currency sales growth ~2%; adjusted EPS $40.20–$40.50 (prior: $39.90–$40.40); 1–2% FX headwind.

  • Adjusted free cash flow and share repurchases both expected at ~$850M for 2024.

  • Management expects sales growth to return in the second half, driven by easier comparisons and sales/marketing initiatives.

  • 2025 will face a ~1.5% sales headwind as delayed 2023 shipments are recaptured in 2024.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more